In this context, we observed that HNSCC patients with GSTT1 present genotype had a decline of almost 5% in renal function, and the reduction in eGFR was of approximately 18% in patients with GSTT1 present and TP53 c.215CC combined genotype. Here, TP53 is linked to head and neck squamous cell carcinoma.